药物遗传学与长期临床演变的关联在脏移植患者队列中
Luis Sendra1,2, Gladys G Olivera-Pasquini1,2, Enrique G Zucchet2
1Gene Therapy and Pharmacogenomics, Department of Pharmacology, University of Valencia, 46010, Valencia, Spain.
Current research in pharmacology and drug discovery
|August 5, 2025
概括
药物遗传变异显著影响移植成功,影响12年内生存率,瘤风险和功能. 个性化基因测试可以优化免疫抑制疗法和患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药物基因组学 药物基因组学
- 移植免疫学 移植免疫学
背景情况:
- 药物遗传变异性影响移植患者的免疫抑制药物的疗效和安全性.
- 移植的长期结果受到个体遗传构成的影响.
研究的目的:
- 研究移植受体中药基因变异和临床结果之间的长期关联.
- 评估基因变异对12年生存,功能,瘤发生和药物药理动学的影响.
主要方法:
- 在79名移植患者中分析了来自14个基因的37个单核酸多态 (SNP).
- 利用后勤回归和卡普兰-梅尔分析来评估基因变异和临床结果之间的关联.
- 评估的临床参数包括患者存活率,功能,瘤发病率和塔克罗利斯的药理动力学.
主要成果:
- CYP3A5,CYP2B6,ABCB1和ABCC2基因的变异与12年生存率有关.
- 捐赠者的ABCC2变体增加了瘤风险,而接受者的CYP2B6 rs3745274则降低了瘤风险.
- 功能,塔克罗利斯水平和毒性风险受到CYP3A4,CYP3A5,CYP2B6,CYP2C19,ABCB1,ABCC2和SLCO1B1.1.的变异的显著影响.
结论:
- 药物基因变异是长期移植结果的关键决定因素.
- 代谢器和转运基因中的特定变异与生存,瘤风险,功能和药物反应相关.
- 药物遗传学测试对于个性化免疫抑制疗法和改善移植接受者的管理至关重要,因此需要进一步验证.
相关概念视频
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:16Kidney Transplant III: Nursing Management
82
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
82
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
229
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
229
01:11Renal Failure: Dose Adjustments
158
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
158
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114
01:12Analysis of Population Pharmacokinetic Data
385
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
385